Subscribe

  • How Can We Help You?

    Global Problem Solving from Covington: Deal with Complex Problems Anywhere in the World

    • Apr 08, 2021
J. D. Weinberg

J. D. Weinberg

Partner

New York +1 212 841 1037

  • About
  • Representative Matters
  • Credentials
  • About

    J. D. Weinberg has been advising companies on their most important strategic transactions for over 30 years. He represents buyers, sellers, and financial advisors in connection with domestic and cross-border mergers and acquisitions transactions, including acquisitions of public companies, negotiated sales of private companies, private equity transactions, and strategic investments.   J. D. has advised numerous boards of directors in change of control situations and governance matters.

    J. D. leads the firm’s Mergers & Acquisitions group.

    J. D. regularly represents companies across a wide array of industries, including technology, life sciences, financial services, consumer products, and industrials.

    J. D. is a member of the Committee on Mergers, Acquisitions and Proxy Contests of the New York City Bar Association. He serves on the advisory board of Young New Yorkers, which runs arts-based diversion programs to court-involved young people in New York City.

    J. D. has been consistently recognized as a leading M&A lawyer by Chambers USA, Legal 500 US, and New York Super Lawyers.

    Areas of Expertise

  • Practices and Industries
  • Representative Matters
    • Oregon Steel Mills (NYSE: OSM) in its acquisition by Evraz Group SA.
    • The Goodyear Rubber & Tire Company in the sale of its Engineered Products Division to The Carlyle Group. 
    • Supervisory Board of Peugeot SA in its merger with Fiat Chrysler, creating Stellantis
    • Independent Directors of Discovery, Inc. in its combination with WarnerMedia through a Reverse Morris Trust transaction and spin-off from AT&T (financial advisor).
    • Thomson Reuters in the sale of its Healthcare division to Veritas Capital and its acquisitions of Information Holdings Inc. (NYSE: IHI) and Solucient. 
    • Johnson & Johnson in its acquisitions of Torax Medical, Sentio, Megadyne, NeuWave, X01, SterilMed, RespiVert, Acclarent, SurgRx, Olive Medical, Link Spine Group, Egea Biosciences, and TransForm Pharmaceuticals, in the sale of its global Splenda® business to Centerbridge Partners and Heartland Food Products Group, its Asia Pacific oral care business to LG Household & Healthcare and its COMPEED® business to HRA Pharma, Valchlor/Ledaga to Helsinn, RoC Skincare to Gryphon Investors, and in other divestitures to Energizer Holdings, Valneva, Air Liquide, and Trimb Healthcare AB.
    • Hewlett Packard Enterprise in its acquisitions of Scytale, BlueData, Plexxi, Cloud Cruiser, CloudPhysics, and the business assets of MapR.
    • Pfizer in its acquisitions of CovX, Rinat Neuroscience, and Bioren. 
    • UCB in its acquisition of Ra Pharmaceuticals (NASDAQ: RARX), in the sale of its specialty generics division to Lannett and, previously, the announced sale to Advent International and Avista Capital Partners, in its acquisitions of Engage Therapeutics, Element Genomics, Beryllium, LLC and the rights to Proximagen’s Midazolam, in its investment in Dermira and in connection with its collaboration with Amgen.
    • Memory Pharmaceuticals Corp. (NASDAQ: MEMY) in its sale to Roche Group.
    • NYSE Euronext in its acquisition by IntercontinentalExchange and in its abandoned merger with Deutsche Börse AG (financial advisor).
    • CA in its acquisitions of Platinum Technology (NASDAQ: PLAT) and Sterling Software (NYSE: SSW), two of the largest software deals at the time.
    • BBVA Compass Bank in its acquisition of Simple Finance Technology.
    • MidFirst Bank in its acquisitions of 1st Century Bancshares, Inc. (NASDAQ: FCTY), of Presidential Financial Corporation from Harbert Private Equity and the Belfer family and of Steele Street Bank & Trust.
    • Altria Group’s investment in JUUL Labs and UST in its sale to Altria (financial advisor).
    • Tetragon Financial Group in the merger of its GreenOak Real Estate joint venture with Sun Life Financial Inc.’s Bentall Kennedy firm. 
    • Kate Spade & Company in its sale to Coach (financial advisor).
    • International Coal Group in its sale to Arch Coal (financial advisor).
    • UBS in its acquisition of Enron's gas and power trading business, including its Enron Online trading platform.
    • International Steel Group in its sale to Mittal Steel (financial advisor).
    • National Amusements in its acquisition of a controlling interest in Midway Games (NYSE: MWY) from Sumner Redstone.
    • Orix Corporation in its unsolicited offer to acquire Criimi Mae (NYSE: CMM).
    • Freddie Mac in connection with establishment of Federal government conservatorship.
    • Gilead Sciences in its acquisition of CGI Pharmaceuticals. 
    • The special committee of JCrew in its sale to TPG and Leonard Green Partners (financial advisor).
    • IAC/InterActiveCorp in its senior notes offering and in its acquisition of Interval International (NASDAQ: IILG).
    • Interpublic in its acquisition of Adair-Greene.
    • Sotheby’s in the sale of its real estate brokerage to Realogy, including in the long-term license of the Sotheby’s trademark.
    • Duke Energy in its merger with Cinergy (financial advisor).
    • Esmark in its proposed acquisition by Essar, and ultimate acquisition by Severstal (financial advisor).
    • Wheeling-Pittsburgh Corporation in its merger with Esmark Inc. (financial advisor) and in its proposed acquisition of the North American assets of Companhia Siderurgica Nacional (financial advisor).
    • Private equity investments in Northeast Bancorp (NASDAQ: NBN), Grandpoint Capital in connection with its acquisition of Santa Ana Bank, and Carlile Bancshares in connection with its acquisition of Treaty Oak Bank.
    • Sims Group Limited in its acquisition of Metal Management, Inc. (financial advisor).
    • Bowater in its merger with Abitibi (financial advisor).
    • Meda AB in its acquisition of a portfolio of pharmaceutical products from Jazz Pharmaceuticals.
    • Cash America International in connection with its merger of equals with First Cash Financial Services (financial advisor).
    • Pactiv in its sale to Reynolds (financial advisor).
    • Ionics in its sale to General Electric (financial advisor).
    • OMI Corporation in its sale to Teekay Shipping and Torm (financial advisor).
    • Validus Holdings in its unsolicited offer to acquire IPC Holdings following IPC's announcement of a proposed amalgamation with Max Capital Group (financial advisor).

    Areas of Expertise

  • Credentials
    Education
    • University of Texas School of Law, J.D., 1990
        • cum laude
        • Order of the Coif
    • University of London, 1989
    • Georgetown University, School of Foreign Service, B.S.F.S., 1987
        • cum laude
    Bar Admissions
    • New York
    Accolades

    Mr. Weinberg has been selected repeatedly for inclusion in Chambers USA, America's Leading Business Lawyers, Corporate/M&A (New York); Chambers Global, Corporate/M&A;  Legal 500 US, Mergers & Acquisitions - M&A: Large Deals; Best Lawyers in America, Leveraged Buyouts and Private Equity Law; Who's Who Legal, Life Sciences – Transactional; and New York Super Lawyers, Mergers & Acquisitions.
    Memberships and Affiliations
    • Committee on Mergers, Acquisitions and Proxy Contests, Association of the Bar of the City of New York, appointed Member (2009-2012; 2013-present)
    • Columbia University, Board of Visitors of the Department of History, Member

    Areas of Expertise

News and Insights